Transmucosal deliver of a drug
GB2632261APending Publication Date: 2025-02-05STATE MODE MEDICAL
Patent Information
- Application Number
- GB2023011643
- Authority / Receiving Office
- GB · GB
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-07-28
- Publication Date
- 2025-02-05
Smart Images
Figure 00000000_0000_ABST
Abstract
A dissolvable lozenge for transmucosal delivery of a neuroactive, psychoactive and / or bioactive compound during dissolution in the mouth of a human or animal subject, the lozenge comprising: a plurality of layers, each comprising a matrix material and the compound, wherein a first layer of the plurality of layers comprises a first matrix material and a first concentration of the compound suspended in the first matrix for delivering a first dosage profile to the human or animal subject, wherein a second layer of the plurality of layers comprises a second matrix material and a second concentration of the or a further compound suspended in the second matrix for delivering a second dosage profile to the human or animal subject. Preferably, the compound is psilocybin or psilocyn. The matrix material may comprise a sugar-based substance, a cellulose derivative and / or a polymer. Preferably, the first layer is adjacent the second layer.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
A suction port of a vacuum cleaner
JP1984013262U
Oral formulations of psychotropic macrofungus botanical extracts with mouthfeel experience enhancers
US20220331344A1
Compositions for delivering 5-HT agonists across the oral mucosa and methods of use thereof
WO2005018565A2
Bilayer adhering lozenge effective to mask undesirable flavor
WO2019204708A1
Extended release 5-HT receptor agonists for neurological conditions
WO2022023812A1